Single use Bioprocessing Sales

Single-Use Bioprocessing Sales Market Outlook

The global Single-Use Bioprocessing market is projected to reach approximately USD 28.94 billion by 2035, with a compound annual growth rate (CAGR) of 16.2% during the forecast period of 2025 to 2035. The increasing demand for biopharmaceuticals and advancements in bioprocessing technology significantly drive the growth of this market. Additionally, the rising preference for cost-effective and efficient biomanufacturing solutions is propelling the adoption of single-use systems. The continuous innovation in bioprocessing tools, along with a growing focus on reducing contamination risks, is further enhancing market growth. This growing trend is complemented by the increasing regulatory approvals for single-use solutions, which support their widespread implementation in various bioprocessing applications.

Growth Factor of the Market

The Single-Use Bioprocessing market is largely driven by the increasing shift towards flexible manufacturing practices, allowing for significant reductions in operational costs and time. The rapid development of biologics and biosimilars has created a pressing need for efficient production technologies which single-use systems can readily provide. Moreover, the ongoing advancements in bioprocessing technologies are enhancing the capabilities and performance of single-use solutions, making them more appealing to manufacturers. Additionally, the expansion of the biopharmaceutical sector, especially in developing regions, is creating ample opportunities for single-use bioprocessing solutions. Increasing investments in biotechnology research and development, combined with the need for rapid scalability in production processes, further contribute to the market's growth. These factors collectively ensure that single-use systems remain a pivotal technology in modern biomanufacturing.

Key Highlights of the Market

• The market is expected to grow at a CAGR of 16.2% from 2025 to 2035.
• Significant increase in demand for biopharmaceuticals driving market growth.
• Technological advancements enhancing performance and capabilities of single-use systems.
• Growing focus on contamination reduction is boosting the adoption of single-use solutions.
• Expansion of the biopharmaceutical sector in developing regions creates new opportunities.

By Product Type

Bioreactors:

Bioreactors are vital components in the single-use bioprocessing market, offering significant advantages such as flexibility, reduced contamination risk, and lower operational costs. These systems provide an environment conducive to microbial or cell culture growth, which is critical for the production of biopharmaceuticals. The adoption of single-use bioreactors allows for efficient scalability and faster turnaround times in production processes. As biopharmaceutical companies increasingly seek to enhance their production capabilities while minimizing contamination risks, the demand for single-use bioreactors continues to rise. Furthermore, innovations in bioreactor design and functionality, such as integrated sensors for real-time monitoring, are further driving the market's growth in this segment.

Filtration Systems:

Filtration systems are integral to the single-use bioprocessing landscape, helping in the purification and separation of various biomolecules. These systems play a crucial role in ensuring product quality and safety by effectively removing contaminants and impurities during the production process. The growing emphasis on stringent regulatory standards in the biopharmaceutical industry is propelling the adoption of filtration systems that utilize single-use technologies. Moreover, advancements in membrane technology and the development of high-performance filters are enhancing the efficacy of filtration systems, making them more efficient and reliable. This has resulted in increased demand for single-use filtration systems, particularly in applications such as vaccine production and monoclonal antibody purification.

Bags:

Single-use bags are widely used in bioprocessing applications for storage and transportation of various biological products, cell cultures, and media. These bags are designed to minimize the risk of cross-contamination, thus ensuring the integrity of the bioproducts. The flexibility and ease of use associated with single-use bags are driving their adoption among biopharmaceutical manufacturers. With the rise of personalized medicine and the need for efficient production systems, the demand for single-use bags is expected to grow substantially. Additionally, advancements in material science have led to the development of high-quality, robust bags that can withstand the rigors of bioprocessing, thereby enhancing their appeal in this market segment.

Tubing:

Tubing is another critical component of single-use bioprocessing systems, enabling the transfer of fluids between different stages of the bioprocess. The demand for single-use tubing solutions is growing as manufacturers look to reduce the risk of contamination and optimize their production workflows. Single-use tubing is often made from advanced materials that ensure compatibility with various bioprocessing applications while maintaining the integrity of the product. Additionally, innovations in tubing design, such as pre-sterilized options and customizable lengths and diameters, are catering to the unique needs of biopharmaceutical companies. This growth in the single-use tubing segment is expected to continue as companies increasingly prioritize efficiency and flexibility in their bioprocessing operations.

Sensors:

Sensors play a pivotal role in single-use bioprocessing systems by providing real-time data on critical process parameters such as pH, temperature, and dissolved oxygen levels. The integration of sensors into single-use bioprocessing solutions enables better monitoring and control of bioprocess conditions, thereby ensuring the quality and consistency of the final products. As the demand for higher efficiency and productivity in biopharmaceutical manufacturing increases, the adoption of sensor technologies is set to rise. Furthermore, advancements in sensor technology, coupled with the growing trend of automation in the bioprocessing industry, are driving the market for single-use sensors. This trend not only enhances the overall efficacy of bioprocessing but also aids in the compliance with stringent regulatory requirements.

By Application

Vaccine Production:

The application of single-use bioprocessing technologies in vaccine production has gained significant traction due to the increasing global demand for vaccines, especially highlighted during the COVID-19 pandemic. Single-use systems offer the flexibility and scalability required to meet the urgent need for vaccine production. They reduce contamination risks and ensure faster turnaround times, which are crucial in vaccine manufacturing. Furthermore, the ability to easily adapt single-use systems for various vaccine types, including mRNA and viral vector vaccines, enhances their appeal. As the biopharmaceutical industry continues to invest in vaccine research and development, the single-use bioprocessing market will likely see substantial growth in this application segment.

Cell Culture:

Cell culture applications are central to the development and production of a range of biopharmaceutical products, including monoclonal antibodies and recombinant proteins. Single-use bioprocessing technologies provide significant advantages in cell culture, such as reduced risk of cross-contamination and lower operational costs. The flexibility of single-use systems allows for rapid scale-up and scale-down, catering to varying production demands. Additionally, the ease of use and the elimination of the need for extensive cleaning and sterilization processes make single-use systems particularly attractive for cell culture applications. As the biopharmaceutical sector continues to evolve, the demand for single-use technologies in cell culture is expected to grow steadily.

Purification:

Purification processes are critical in the production of biopharmaceuticals, ensuring that the final products meet the necessary safety and efficacy standards. Single-use bioprocessing solutions streamline the purification process by providing dedicated systems that minimize contamination risks and allow for more efficient workflows. The demand for single-use purification technologies is rising as biopharmaceutical companies look for ways to enhance product yield and quality. Moreover, advancements in purification technologies, including the use of single-use chromatography systems, are contributing to the growth of this segment. As regulatory requirements continue to evolve, the adoption of single-use technologies for purification applications is expected to gain further momentum.

By User

Biopharmaceutical Companies:

Biopharmaceutical companies are the primary users of single-use bioprocessing technologies, utilizing these systems to streamline their production processes and enhance efficiency. These companies seek to reduce operational costs, minimize contamination risks, and scale their production capabilities to meet increasing demands for biopharmaceutical products. The shift towards single-use systems allows biopharmaceutical manufacturers to focus on innovation and product development without the burden of extensive cleaning and validation processes typically associated with traditional systems. As the biopharmaceutical sector continues to grow, the reliance on single-use technologies is expected to increase, further driving market expansion in this user segment.

Contract Development and Manufacturing Organizations:

Contract Development and Manufacturing Organizations (CDMOs) play a crucial role in the biopharmaceutical supply chain, offering comprehensive services that include development and manufacturing of biopharmaceutical products. CDMOs are increasingly adopting single-use bioprocessing technologies to enhance their operational efficiency and reduce turnaround times for their clients. The flexibility and scalability of single-use systems enable CDMOs to cater to a diverse clientele, ranging from small biotech firms to large pharmaceutical companies. As the demand for outsourcing continues to rise in the biopharmaceutical industry, CDMOs' adoption of single-use technologies will likely expand, driving the overall market growth.

By Technology

Disposable:

Disposable technologies are central to the single-use bioprocessing market, providing biomanufacturers with versatile and efficient solutions that minimize contamination risks. The trend towards disposable solutions is driven by the growing demand for faster production cycles and the need for enhanced flexibility in biomanufacturing processes. Disposable systems eliminate the need for extensive cleaning and validation, thus reducing downtime between batches. With the increasing complexity of biopharmaceutical products, the adoption of disposable technologies is expected to rise, as they support rapid scale-up and adaptation to different production requirements. As biopharmaceutical manufacturing continues to evolve, the disposable technology segment will play a pivotal role in shaping the future of bioprocessing.

Reusable:

Reusable technologies have traditionally been the mainstay of bioprocessing; however, their adoption is facing challenges in the context of evolving production demands and regulatory requirements. While reusable systems offer potential cost benefits over the long term, they require extensive cleaning, validation, and maintenance, which can lead to increased operational complexities. The market for reusable systems is gradually transitioning as biomanufacturers shift towards more efficient and flexible single-use solutions. Nevertheless, reusable technologies still hold value in large-scale operations where cost efficiency is paramount, and companies are willing to invest in the infrastructure necessary to support their use. The future of reusables will depend on innovations aimed at enhancing their efficiency and reducing associated risks.

By Region

North America dominates the global Single-Use Bioprocessing market, accounting for approximately 45% of the market share. This region is characterized by a robust biopharmaceutical industry, with numerous leading companies and extensive research and development activities. The increasing prevalence of chronic diseases and the growing demand for biologics significantly contribute to the market's expansion in North America. Furthermore, advancements in bioprocessing technologies and a strong focus on innovation and efficiency are driving the growth of single-use systems in this region. The CAGR for North America is projected to be around 15.8% from 2025 to 2035, showcasing its significant growth potential.

Europe holds a substantial share of the Single-Use Bioprocessing market, accounting for approximately 30% of the total market size. The region benefits from strong regulatory frameworks and a growing emphasis on compliance within the biopharmaceutical industry. Additionally, the increasing number of biopharmaceutical companies and the rising investment in biotechnology research contribute to market growth in Europe. The Asia Pacific region is also witnessing growth due to the expansion of biopharmaceutical manufacturing capabilities and increasing investments from various countries. As the market matures, a notable CAGR of around 16.5% is anticipated for the Asia Pacific region, reflecting its potential to become a major player in the global single-use bioprocessing landscape.

Opportunities

The Single-Use Bioprocessing market presents numerous opportunities driven by the increasing demand for biopharmaceuticals and the need for efficient manufacturing solutions. One of the key opportunities lies in the rising focus on personalized medicine, which necessitates more agile and flexible production processes. Single-use systems allow manufacturers to rapidly adapt their production lines, catering to the unique specifications of personalized therapies. This adaptability is particularly crucial as biopharmaceutical companies aim to offer targeted treatments to specific patient populations. Moreover, the growing prevalence of chronic diseases and aging populations around the globe will likely further bolster the demand for biopharmaceutical solutions, creating an expanded market for single-use bioprocessing technologies.

Another significant opportunity in the single-use bioprocessing market is the increasing emphasis on sustainability and environmental responsibility within the biopharmaceutical industry. As companies strive to minimize their environmental footprint, the adoption of single-use systems can help reduce water and energy consumption due to their streamlined workflows. Furthermore, innovations in biodegradable and environmentally friendly materials for single-use products can enhance the appeal of these technologies to eco-conscious manufacturers. By capitalizing on these emerging trends, companies within the single-use bioprocessing market can position themselves for sustained growth and contribute to a more sustainable future in biopharmaceutical manufacturing.

Threats

Despite the promising growth prospects, the Single-Use Bioprocessing market faces several threats that could hinder its expansion. One major concern is the potential for increased regulatory scrutiny as the market evolves, which could lead to more stringent compliance requirements for manufacturers. As regulatory bodies aim to ensure product safety and efficacy, they may impose additional guidelines around the use of single-use technologies. This could create challenges for manufacturers that are not equipped to meet these changing standards, resulting in delays and increased operational costs. Moreover, the competitive landscape of the biopharmaceutical industry may intensify with the entry of new players, leading to pricing pressures that could negatively impact profit margins for established companies.

Another threat is the reliance on a limited number of suppliers for critical components of single-use systems, such as bags, tubing, and sensors. This dependence can result in supply chain disruptions if a key supplier faces operational challenges or if there are fluctuations in material costs. Additionally, the ongoing geopolitical uncertainties and trade tensions could impact the availability of raw materials and components required for single-use bioprocessing systems. Manufacturers must develop strategies to mitigate these risks, such as diversifying their supplier base and investing in robust supply chain management practices to ensure continuity and stability in their operations.

Competitor Outlook

• Merck KGaA
• Thermo Fisher Scientific Inc.
• GE Healthcare
• Pall Corporation
• Repligen Corporation
• Avantor, Inc.
• Eppendorf AG
• Sartorius AG
• Danaher Corporation
• Fujifilm Diosynth Biotechnologies
• Lonza Group Ltd.
• Corning Incorporated
• Waters Corporation
• Horizon Discovery Ltd.
• Charles River Laboratories International, Inc.

The competitive landscape of the Single-Use Bioprocessing market is characterized by a diverse mix of established players and emerging companies. Market leaders such as Merck KGaA, Thermo Fisher Scientific, and GE Healthcare dominate the industry, leveraging their extensive product portfolios and strong market presence to maintain a competitive edge. These companies focus on innovation, investing in research and development to create advanced single-use solutions that meet the evolving needs of biopharmaceutical manufacturers. Additionally, strategic partnerships and collaborations are common among these players, allowing them to enhance their service offerings and expand their market reach.

Emerging players, including newer companies such as Repligen Corporation and Avantor, are making significant inroads into the Single-Use Bioprocessing market by offering specialized solutions and tailored services that cater to specific customer needs. These companies often leverage their agility and innovative capabilities to disrupt traditional practices in bioprocessing. As the market continues to grow, collaborations between established and emerging players are likely to increase, fostering innovation and enhancing product offerings across the industry.

Key players like Pall Corporation and Sartorius AG contribute to market dynamics through their commitment to sustainability and environmentally friendly practices. These companies are increasingly focusing on developing biodegradable and recyclable single-use components, aligning their strategies with the growing demand for sustainable solutions in biomanufacturing. This focus on sustainability not only enhances their brand reputation but also positions them favorably in a market where regulatory pressures regarding environmental impact are intensifying. As the Single-Use Bioprocessing market evolves, the competitive landscape will continue to shift, shaped by innovation, sustainability, and the increasing focus on operational efficiency.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Merck KGaA
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Eppendorf AG
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Sartorius AG
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Avantor, Inc.
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 GE Healthcare
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Lonza Group Ltd.
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Pall Corporation
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Waters Corporation
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Danaher Corporation
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Corning Incorporated
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Repligen Corporation
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Horizon Discovery Ltd.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Thermo Fisher Scientific Inc.
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Fujifilm Diosynth Biotechnologies
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Charles River Laboratories International, Inc.
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Single use Bioprocessing Sales Market, By User
    • 6.1.1 Biopharmaceutical Companies
    • 6.1.2 Contract Development and Manufacturing Organizations
  • 6.2 Single use Bioprocessing Sales Market, By Technology
    • 6.2.1 Disposable
    • 6.2.2 Reusable
  • 6.3 Single use Bioprocessing Sales Market, By Application
    • 6.3.1 Vaccine Production
    • 6.3.2 Cell Culture
    • 6.3.3 Purification
  • 6.4 Single use Bioprocessing Sales Market, By Product Type
    • 6.4.1 Bioreactors
    • 6.4.2 Filtration Systems
    • 6.4.3 Bags
    • 6.4.4 Tubing
    • 6.4.5 Sensors

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Single use Bioprocessing Sales Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Single use Bioprocessing Sales market is categorized based on

By Product Type

• Bioreactors
• Filtration Systems
• Bags
• Tubing
• Sensors

By Application

• Vaccine Production
• Cell Culture
• Purification

By User

• Biopharmaceutical Companies
• Contract Development and Manufacturing Organizations

By Technology

• Disposable
• Reusable

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Merck KGaA
• Thermo Fisher Scientific Inc.
• GE Healthcare
• Pall Corporation
• Repligen Corporation
• Avantor, Inc.
• Eppendorf AG
• Sartorius AG
• Danaher Corporation
• Fujifilm Diosynth Biotechnologies
• Lonza Group Ltd.
• Corning Incorporated
• Waters Corporation
• Horizon Discovery Ltd.
• Charles River Laboratories International, Inc.